BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1315 related articles for article (PubMed ID: 28179656)

  • 1. Inflammation, metaflammation and immunometabolic disorders.
    Hotamisligil GS
    Nature; 2017 Feb; 542(7640):177-185. PubMed ID: 28179656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foundations of Immunometabolism and Implications for Metabolic Health and Disease.
    Hotamisligil GS
    Immunity; 2017 Sep; 47(3):406-420. PubMed ID: 28930657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of interleukins in obesity: implications for metabolic disease.
    Febbraio MA
    Trends Endocrinol Metab; 2014 Jun; 25(6):312-9. PubMed ID: 24698032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory mechanisms in obesity.
    Gregor MF; Hotamisligil GS
    Annu Rev Immunol; 2011; 29():415-45. PubMed ID: 21219177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunomodulating role of exercise in metabolic disease.
    Lancaster GI; Febbraio MA
    Trends Immunol; 2014 Jun; 35(6):262-9. PubMed ID: 24680647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive Immunity and Metabolic Health: Harmony Becomes Dissonant in Obesity and Aging.
    Bharath LP; Ip BC; Nikolajczyk BS
    Compr Physiol; 2017 Sep; 7(4):1307-1337. PubMed ID: 28915326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoplasmic reticulum stress and inflammation in obesity and diabetes.
    Hummasti S; Hotamisligil GS
    Circ Res; 2010 Sep; 107(5):579-91. PubMed ID: 20814028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunometabolism: Molecular Mechanisms, Diseases, and Therapies 2016.
    Rosa Neto JC; Lira FS; Roy S; Festuccia W
    Mediators Inflamm; 2017; 2017():8230298. PubMed ID: 28757685
    [No Abstract]   [Full Text] [Related]  

  • 9. Emerging concepts in intestinal immune control of obesity-related metabolic disease.
    Khan S; Luck H; Winer S; Winer DA
    Nat Commun; 2021 May; 12(1):2598. PubMed ID: 33972511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutrient sensing and inflammation in metabolic diseases.
    Hotamisligil GS; Erbay E
    Nat Rev Immunol; 2008 Dec; 8(12):923-34. PubMed ID: 19029988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of MicroRNAs in Obesity-Induced Metabolic Disorder and Immune Response.
    Zhong H; Ma M; Liang T; Guo L
    J Immunol Res; 2018; 2018():2835761. PubMed ID: 29484304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA Regulators of Anxiety and Metabolic Disorders.
    Meydan C; Shenhar-Tsarfaty S; Soreq H
    Trends Mol Med; 2016 Sep; 22(9):798-812. PubMed ID: 27496210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammasome activation and metabolic disease progression.
    Li HB; Jin C; Chen Y; Flavell RA
    Cytokine Growth Factor Rev; 2014 Dec; 25(6):699-706. PubMed ID: 25156419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate sensors of pathogen and stress: linking inflammation to obesity.
    Jin C; Flavell RA
    J Allergy Clin Immunol; 2013 Aug; 132(2):287-94. PubMed ID: 23905917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxysterols in Metabolic Syndrome: From Bystander Molecules to Bioactive Lipids.
    Guillemot-Legris O; Mutemberezi V; Muccioli GG
    Trends Mol Med; 2016 Jul; 22(7):594-614. PubMed ID: 27286741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy is an inflammation-related defensive mechanism against disease.
    Joven J; Guirro M; Mariné-Casadó R; Rodríguez-Gallego E; Menéndez JA
    Adv Exp Med Biol; 2014; 824():43-59. PubMed ID: 25038993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Bridge Proteins" Link Inflammation and Metabolic Diseases: Potential Targets for Therapeutics.
    Jiang H; Qin G; Zhang X; Che D
    Curr Protein Pept Sci; 2017; 18(6):619-629. PubMed ID: 27356936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Obesity, inflammation and diabetes].
    Miranda-Garduño LM; Reza-Albarrán A
    Gac Med Mex; 2008; 144(1):39-46. PubMed ID: 18619057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation, obesity, and the promise of immunotherapy for metabolic disease.
    O'Rourke RW
    Surg Obes Relat Dis; 2013; 9(5):609-16. PubMed ID: 22959472
    [No Abstract]   [Full Text] [Related]  

  • 20. Fat-resident Tregs: an emerging guard protecting from obesity-associated metabolic disorders.
    Chen X; Wu Y; Wang L
    Obes Rev; 2013 Jul; 14(7):568-78. PubMed ID: 23534927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.